首页> 外文期刊>Comparative Effectiveness Research >Challenges conducting comparative effectiveness research: the Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE) experience
【24h】

Challenges conducting comparative effectiveness research: the Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE) experience

机译:进行比较有效性研究的挑战:比较有效性的临床和健康成果计划(CHOICE)经验

获取原文
       

摘要

Abstract: The Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE) program, which includes 12 ongoing comparative effectiveness research (CER) trials funded by the Agency for Healthcare Research and Quality under the American Recovery and Reinvestment Act of 2009, has had firsthand experience in dealing with the unique challenges of conducting CER since the trials started in the fall of 2010. This paper will explore the collective experience of the CHOICE program and discuss common challenges and successes the CHOICE investigators have experienced conducting CER research in the United States. The specific aims of this paper are to describe the common features of the CHOICE award studies (observational studies and trials), to summarize the strategies undertaken to address the challenges in conducting comparative effectiveness pragmatic trials and observational studies from the patient, physician, and administrative perspective, and to provide recommendations for improving the efficiency and feasibility of conducting prospective CER studies in the future.
机译:摘要:比较有效性的临床和健康成果计划(CHOICE)计划具有第一手经验,该计划包括12项正在进行的比较有效性研究(CER)试验,该试验由美国医疗保健研究与质量局根据2009年美国复苏与再投资法案资助。自2010年秋季开始试验以来,在应对进行CER的独特挑战方面。本文将探讨CHOICE计划的集体经验,并讨论CHOICE研究人员在美国进行CER研究时遇到的常见挑战和成功经验。本文的具体目的是描述CHOICE奖励研究(观察性研究和试验)的共同特征,总结为应对挑战进行的策略,以应对来自患者,医师和行政管理人员的比较实用性试验和观察性研究观点,并为提高未来进行前瞻性CER研究的效率和可行性提供建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号